Google’s AlphaGenome 2 zooms in on the cellular roots of disease

DeepMind's new AI model, AlphaGenome 2, is designed to predict how changes in DNA affect different cells, potentially leading to new treatments for diseases. The model was trained on over 100 million individual cell profiles across 68 tissues and is more detailed than its predecessor, AlphaGenome. It can identify nearly twice as many genetic variants that affect gene expression in cells, and can even make predictions about new types of cells and biological systems. The model's finer-grained view of cellular differences could reveal disease-relevant effects that might otherwise go unnoticed.